Skip to main content

Sedana Medical

Sedana Medical AB is a Swedish medical technology and pharmaceutical company focused on inhaled sedation in intensive care units. The company develops and markets the AnaConDa medical device alongside its proprietary pharmaceutical formulation Sedaconda, transforming intravenous sedation into inhaled sedation. Main revenue drivers comprise sales of the Sedaconda medical device line, pharmaceutical supply sales, and accessories to hospital intensive care departments. Sedana Medical serves intensive care physicians, critical care units, anesthesiologists, and hospital networks across Europe and international expansion markets. The company holds a pioneering market position as the sole provider of inhaled sedation solutions for intensive care patients. Headquartered in Danderyd, Sweden, Sedana Medical AB is listed on Nasdaq Stockholm.

5 of the funds FundTelligence covers report a position in Sedana Medical.

Legal name
Sedana Medical AB
Sector
Health Care
Country
Sweden
Funds holding it
5

Funds holding Sedana Medical

Loading...